CLINICAL GENOMICS: YOUR PARTNER IN EARLIER DETECTION.

InSure® ONE™ is a highly accurate test for detecting blood in fecal samples.

COLVERA is a liquid biopsy test designed to detect early recurrence of colorectal cancer.

InSure ONE

InSure ONE is an easy, one-day fecal immunochemical test that uses a sample of water collected with a brush to detect lower GI bleeding.

DETECTING RESIDUAL DISEASE

COLVERA is a clinically validated circulating tumor DNA (ctDNA) blood test designed to detect residual disease after surgical resection in CRC patients.

RECURRENCE MONITORING

COLVERA is a clinically validated ctDNA blood test designed to detect recurrent disease after primary treatment in CRC patients.

TECHNOLOGY

Clinical Genomics harnesses breakthrough science to create innovative and accessible ways to detect disease and enhance lives.

COMPANY

Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management.

CONTACT US

For more information about Clinical Genomics and our products.

Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission

Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission Bridgewater, NJ – Thursday November 29, 2018 Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced...

Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs

Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs Bridgewater, NJ – Thursday November 1, 2018 Relationship ensures broad access to innovative FIT test...

Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer

Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer Bridgewater, NJ – Friday October 26, 2018 Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy Hanna...

Two new Board of Director appointments to liquid biopsy company Clinical Genomics

Two new Board of Director appointments to liquid biopsy company Clinical Genomics Bridgewater, NJ – Tuesday October 16, 2018 Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two new appointments...

Social Icons

Facebook Twitter LinkedIn

Copyright © 2018 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.